Why is Hester Bios falling/rising?

As of 12-Nov, Hester Biosciences Ltd is experiencing a price increase, currently at Rs 1,698.00, reflecting a rise of 57.2 points or 3.49%. The stock has shown a strong performance today, outperforming its sector by 2.51% and achieving a consecutive gain over the last four days, with a total increase of 6.65% during this period. It reached an intraday high of Rs 1,748, although it also faced volatility, trading within a wide range of Rs 169.1. Despite this positive movement, the stock has a mixed performance in the longer term, with a year-to-date decline of 29.03% and a one-year return of -34.09%. The company has reported positive financial results, including a 63.93% growth in net profit and strong operating cash flow, but it also faces concerns regarding its long-term fundamental strength, with a low return on capital employed and high debt levels.
In the broader market context, Hester Biosciences has outperformed the Sensex in the short term, with a weekly return of 5.87% compared to the benchmark's 1.21%. However, the stock's long-term performance remains concerning, as it has underperformed against the BSE500 over the past year and three years. The lack of domestic mutual fund investment suggests a cautious outlook from institutional investors, which may reflect broader market sentiments about the company's valuation and growth potential. Overall, while the recent price increase is encouraging, the stock's long-term challenges and investor participation issues may temper enthusiasm.